MOTT RICHARD W 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Mar 31, 2023
Insider Transaction Report
Form 4
MOTT RICHARD W
Director
Transactions
- Sale
Common Stock
2023-03-30$26.00/sh−38,498$1,000,998→ 1,020,000 total - Sale
Common Stock
2023-03-31$25.36/sh−95,000$2,409,029→ 925,000 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes 2,295 RSUs.
- [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.9050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.